반응식
[F:1][CH:2]([F:25])[C:3]1[N:8]2[N:9]=[CH:10][C:11]([C:12]([OH:14])=O)=[C:7]2[N:6]=[C:5]([C:15]2[CH:20]=[CH:19][C:18]([C:21]([F:24])([F:23])[F:22])=[CH:17][CH:16]=2)[CH:4]=1.[NH2:26][C:27]1[S:31][C:30]([S:32]([NH2:35])(=[O:34])=[O:33])=[N:29][N:28]=1>>[S:32]([C:30]1[S:31][C:27]([NH:26][C:12]([C:11]2[CH:10]=[N:9][N:8]3[C:3]([CH:2]([F:25])[F:1])=[CH:4][C:5]([C:15]4[CH:16]=[CH:17][C:18]([C:21]([F:22])([F:24])[F:23])=[CH:19][CH:20]=4)=[N:6][C:7]=23)=[O:14])=[N:28][N:29]=1)(=[O:34])(=[O:33])[NH2:35]참가 물질
3
반응물 2
생성물 1
실험 절차
The title compound was prepared from 7-difluoromethyl-5-(4-trifluoromethyl-phenyl)-pyrazolo[1,5-a]pyrimidine-3-carboxylic acid (example C. 1) and 5-amino-[1,3,4]thiadiazole-2-sulfonic acid amide [commercially available, CAS 14949-00-9] according to general procedure II.
출처 및 근거
- ORD 기록
- ord-004aacf72bfb40c99c7a652cd2dd38f3
- 출처 데이터셋
- uspto-grants-2008_04
- 특허 번호
- US07361659B2
연결된 노트
불러오는 중…